Zhongchao announced that Shanghai Zhongxin Medical Technology, of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, has renewed its service agreement with Beijing Public Health Foundation, a non-profit organization dedicated to enhancing Chinese citizens’ health through public welfare initiatives and aid programs. Pursuant to the Agreement, Zhongxin and BPHF extended its partnership to work together on a patient aid project to provide medication assistance services for cancer patients. The Project offers free Doxorubicin Hydrochloride Liposome Injections to low-income patients with breast cancer, lymphoma, Kaposi’s sarcoma, ovarian cancer, osteosarcoma, and myeloma based on their needs. Under the supervision and guidance of BPHF, Zhongxin, leveraging its self-developed patient assistance program technical service platform, is responsible for providing staff with training and daily operation management, maintaining the project website, management for patients, and monitoring and analyzing project progress.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
